This content is machine translated Epilepsy New anticonvulsants in clinical practice Epilepsy is a disease that has been known for thousands of years, and many therapeutic approaches and substances have been used to treat it. In recent years, the options for…
View Post 2 min This content is machine translated Stroke Secondary Prevention Ticagrelor as add-on leads to significant risk reduction Results from the Phase III THALES trial show that ticagrelor, when taken concomitantly with aspirin, produces a statistically significant and clinically meaningful reduction in stroke recurrences compared with aspirin treatment…
View Post 4 min This content is machine translated Stroke Neuroprotection in focus More than three quarters of all strokes are caused by an occlusion or narrowing of a blood vessel supplying the brain. This results in a reduced supply of oxygen and…
View Post 3 min This content is machine translated Polyneuropathies Therapy management for peripheral nerve diseases Polyneuropathies are generalized disorders of the peripheral nervous system and, with a prevalence of 5-8%, are most common in patients with chronic alcohol abuse, diabetes, or malignancies. In addition to…
View Post 3 min This content is machine translated Therapy management of multiple sclerosis Individual, competent, holistic – the right therapy for the MS patient The number of people with MS in Switzerland is increasing. Current surveys paint an alarming picture. This makes effective treatment that is individually adapted to the patient’s life situation and…
View Post 5 min This content is machine translated Parkinson's disease From clinical syndrome to molecular diagnostics and modern therapy Parkinson’s syndrome is one of the most common neurodegenerative diseases. Symptoms such as limitations in movement control are based on a loss of nerve cells in the affected areas of…
View Post 2 min This content is machine translated Pharmacoresistant focal epilepsy. Innovative neurostimulation procedure raises hope Epilepsy is considered one of the most common chronic neurological conditions and severely limits the quality of life of those affected. Despite a wide range of options, current therapeutic options…
View Post 3 min This content is machine translated Medical cannabis With pain the substance begins to act The use of medicinal cannabinoids that are reimbursable through health insurance has come a long way in recent years. This is also reflected in various consensus statements and current guidelines.…
View Post 9 min This content is machine translated New in the treatment of schizophrenia Similarities and differences among partial dopamine agonists. Antipsychotics are the mainstay of acute and long-term treatment for schizophrenic disorders. The earlier antipsychotic treatment begins, the greater the chance of controlling or stopping the progression of psychosis.
View Post 2 min This content is machine translated Multiple sclerosis Study results suggest increased cancer risk As a large Norwegian study showed, patients with multiple sclerosis (MS) have a higher risk of developing cancer – particularly of the respiratory and central nervous systems – compared with…
View Post 10 min This content is machine translated Gilles de la Tourette syndrome Functional tics or Tourette’s – the subtle difference Gilles de la Tourette syndrome (GTS) is one of the common neuropsychiatric disorders. It is predominantly genetically determined and is based on neuroanatomical and neurophysiological abnormalities. Accordingly, the disease is…
